The Delhi government has announced plans to establish a special committee to address the growing concern of counterfeit medicines in the capital, with a mandate to conduct systematic raids and ensure patient safety.
According to The Economic Times, the committee will be constituted by the state health department and include four specialised teams responsible for carrying out surprise operations across the city. Officials indicated that many of these inspections will take place at night in areas near hospitals and medical shops, where the sale of fake drugs is suspected to be most active. Seized products will undergo rigorous laboratory testing to verify their authenticity.
Delhi Health Minister Pankaj Singh stated that the move follows a series of recent cases in which counterfeit medicines were found circulating in the market, raising serious public health concerns. Emphasising a zero-tolerance approach, Singh said the government’s priority is to prevent fraudulent drugs from reaching patients. “The newly formed committee will work round the clock to identify sources, conduct raids, and ensure no fake medicines reach the people of Delhi,” he noted.
The circulation of counterfeit medicines poses a significant risk to both public health and the integrity of the pharmaceutical supply chain. For hospitals, pharmacies, and manufacturers, such developments underscore the need for stricter enforcement, better tracking systems, and stronger collaboration between regulators and industry. India, one of the world’s largest producers of generic medicines, has faced scrutiny in recent years over issues of quality control and compliance, making local interventions like Delhi’s especially relevant.
With the formation of the committee, the Delhi government signals a sharper regulatory focus on curbing counterfeit drug activity, which could also influence broader discussions on pharmaceutical regulation and patient safety across the country.
